Infectious Diseases Research

Scientific Papers

• Martínez Lamas L, Diz Dios P, Pérez Rodríguez MT, Del Campo Pérez V, Cabrera Alvargonzalez JJ, López Domínguez AM, Fernandez Feijoo J, Diniz Freitas M, Limeres Posse J. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2022 Jul;28 Suppl 1:908–11. PMID: 32615642. DOI: 10.1111/odi.13526. http://www.ncbi.nlm.nih.gov/pubmed/32615642 +Pubmed +DOI
• Poveda E, Tabernilla A, Fitzgerald W, Salgado-Barreira Á, Grandal M, Pérez A, Mariño A, Álvarez H, Valcarce N, González-García J, Bernardino JI, Gutierrez F, Fujioka H, Crespo M, Ruiz-Mateos E, Margolis L, Lederman MM, Freeman ML. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control. J Infect Dis. 2022 Jun;225(6):1040–9. PMID: 32603406. DOI: 10.1093/infdis/jiaa375. http://www.ncbi.nlm.nih.gov/pubmed/32603406 +Pubmed +DOI

Scientific Papers

• Antela A, Rivero A, Llibre JM, Moreno S, RET Group [Celia Miralles]. Redefining therapeutic success in HIV patients: an expert view. J Antimicrob Chemother. 2021;76(10):2501–18. PMID: 34077524. DOI: 10.1093/jac/dkab168. http://www.ncbi.nlm.nih.gov/pubmed/34077524 +Pubmed +DOI
• Bacqué J, Delgado E, Benito S, Moreno-Lorenzo M, Montero V, Gil H, Sánchez M, Nieto-Toboso MC, Muñoz J, Zubero-Sulibarria MZ, Ugalde E, García-Bodas E, Cañada JE, Del Romero J, Rodríguez C, Rodríguez-Avial I, Elorduy-Otazua L, Portu JJ, García-Costa J, Ocampo A, Cabrera JJ, Thomson MM. Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Front Microbiol. 2021;12:774386. PMID: 34867914. DOI: 10.3389/fmicb.2021.774386. http://www.ncbi.nlm.nih.gov/pubmed/34867914 +Pubmed +DOI
• Benavent E, Rodríguez-Pardo D, Ulldemolins M, Sobrino-Diaz B, Bustinduy MJ, Escudero-Sanchez R, Nodar A, Sorli L, Del Toro López MD, Bahamonde A, Vilchez HH, Duran J, Muñez E, Rodriguez-Montserrat D, García-País MJ, Pellisé F, Núñez-Pereira S, Caballero-Martinez LF, Cobo J, Pérez-Rodríguez MT, Ariza J, Pigrau C, Murillo O, REIPI (Spanish Network for Research in Infectious Disease)/GEIO–SEIMC (Group for the Study of Osteoarticular Infections – Spanish Society of Infectious Diseases and Clinical Microbiology). Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort. J Antimicrob Chemother. 2021 Mar;76(4):1085–93. PMID: 33496335. DOI: 10.1093/jac/dkaa548. http://www.ncbi.nlm.nih.gov/pubmed/33496335 +Pubmed +DOI
• Berzosa Sánchez A, Jiménez De Ory S, Frick MA, Menasalvas Ruiz AI, Couceiro JA, Mellado MJ, Bisbal O, Albendin Iglesias H, Montero M, Roca C, Samperiz G, Cervero M, Miralles C, Fortuny Guash C, Carrasco I, Navarro ML, Ramos Amador JT, Corispe-Faro Cohort Working Group S. Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain. Pediatr Infect Dis J. 2021;40(4):347–50. PMID: 33264211. DOI: 10.1097/INF.0000000000003009. http://www.ncbi.nlm.nih.gov/pubmed/33264211 +Pubmed +DOI
• Codina H, Vieitez I, Gutierrez-Valencia A, Skouridou V, Martínez C, Patiño L, Botero-Gallego M, Trujillo-Rodríguez M, Serna-Gallego A, Muñoz-Muela E, Bobillo MM, Pérez A, Cabrera-Alvar JJ, Crespo M, O´Sullivan CK, Ruiz-Mateos E, Poveda E. Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1?, Early Predictors of Severe COVID-19. Microorganisms. 2021 Oct;9(11):2259. PMID: 34835384. DOI: 10.3390/microorganisms9112259. http://www.ncbi.nlm.nih.gov/pubmed/34835384 +Pubmed +DOI
• Corma-Gómez A, Macías J, Morano L, Rivero A, Téllez F, Ríos MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera-Méndez FJ, Galindo MJ, Pineda JA, RIS-HEP13 and GEHEP 011 Study Groups. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response. Clin Infect Dis. 2021;72(5):e96–102. PMID: 33211801. DOI: 10.1093/cid/ciaa1726. http://www.ncbi.nlm.nih.gov/pubmed/33211801 +Pubmed +DOI
• Díez C, Del Romero-Raposo J, Mican R, López JC, Blanco JR, Calzado S, Samperiz G, Portilla J, García-Fraile LJ, Gutiérrez F, Gómez-Sirvent JL, Suárez-García I, Amador C, Novella M, Arribas JR, Moreno S, González-García J, Jarrín I, Berenguer J, CoRIS Cohort [Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada]. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. HIV Med. 2021;22(9):867–76. PMID: 34324783. DOI: 10.1111/hiv.13145. http://www.ncbi.nlm.nih.gov/pubmed/34324783 +Pubmed +DOI
• Escolà-Vergé L, Cuervo G, de Alarcón A, Sousa D, Barca LV, Fernández-Hidalgo N, IE COVID-19 investigators (MT Pérez-Rodríguez; A Sousa; M Suárez). Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis. Clin Microbiol Infect. 2021 Apr;27(4):660–4. PMID: 33253944. DOI: 10.1016/j.cmi.2020.11.022. http://www.ncbi.nlm.nih.gov/pubmed/33253944 +Pubmed +DOI
• Gonzalez-Serna A, Corma-Gomez A, Tellez F, García-Martin S, Rivero-Juarez A, Frias M, Vera-Méndez FJ, De Los Santos I, Merino D, Morano L, Imaz A, Galera C, Serrano M, Macias J, Pineda JA. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. J Antimicrob Chemother. 2021;76(9):2375–9. PMID: 34021755. DOI: 10.1093/jac/dkab157. http://www.ncbi.nlm.nih.gov/pubmed/34021755 +Pubmed +DOI
• Grillo S, Cuervo G, Carratala J, San-Juan R, Aguado JM, Morata L, Gomez-Zorrilla S, López-Contreras J, Gasch O, Gomila-Grange A, Iftimie S, Garcia-Pardo G, Calbo E, Boix-Palop L, Oriol I, Jover-Sáenz A, López-Cortés LE, Euba G, Aguirregabiria M, Garcia-Pais MJ, Gioia F, Paño JR, Pedro-Botet ML, Benítez RM, Pérez-Rodríguez MT, Meije Y, Loeches-Yagüe MB, Horna G, Berbel D, Domínguez MÁ, Padullés A, Cobo S, Hereu P, Videla S, Tebe C, Pallarés N, Miro JM, Pujol M, SAFO study group and the Spanish Network for Research in Infectious Diseases (REIPI). Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial. BMJ Open. 2021;11(8):e051208. PMID: 34353808. DOI: 10.1136/bmjopen-2021-051208. http://www.ncbi.nlm.nih.gov/pubmed/34353808 +Pubmed +DOI
• Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J, REIPI-SEIMC COVID-19 group (M Teresa Pérez-Rodríguez; Alexandre Pérez González) and COVID@HULP groups. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021 Feb;21(6):783–92. PMID: 33636145. DOI: 10.1016/S1473-3099(21)00019-0. http://www.ncbi.nlm.nih.gov/pubmed/33636145 +Pubmed +DOI
• Jiménez de Ory S, Beltrán-Pavez C, Gutiérrez-López M, Santos MDM, Prieto L, Sainz T, Guillen S, Aguilera-Alonso D, Díez C, Bernardino JI, Mellado MJ, Ramos JT, Holguín Á, Navarro M, Paediatric Cohort of the Spanish National AIDS Network (CoRISpe and CoRISpe-FARO) (Celia Miralles; Antonio Ocampo; Guille Pousada). Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure. J Antimicrob Chemother. 2021;76(7):1886–92. PMID: 33734374. DOI: 10.1093/jac/dkab080. http://www.ncbi.nlm.nih.gov/pubmed/33734374 +Pubmed +DOI
• Macías J, Téllez F, de Los Santos I, Morano LE, Merino D, Granados R, Vera-Mendez F, González-Serna A, Campo-Moneo E, García-Fraile L, García F, Real LM, Pineda JA, RIS-HEP20 Study and the HEPAVIR and GEHEP Study Groups. Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy. J Viral Hepat. 2021 Jun;28(6):878–86. PMID: 33721377. DOI: 10.1111/jvh.13496. http://www.ncbi.nlm.nih.gov/pubmed/33721377 +Pubmed +DOI
• Marín-Candón A, Rosso-Fernández CM, Bustos de Godoy N, López-Cerero L, Gutiérrez-Gutiérrez B, López-Cortés LE, Barrera Pulido L, Borreguero Borreguero I, León MJ, Merino V, Camean-Fernández M, Retamar P, Salamanca E, Pascual A, Rodriguez-Baño J, ASTARTÉ Study Group [Maria Teresa Pérez Rodríguez; Francisco José Vasallo Vidal; Adrián Sousa Domínguez]. Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial. BMJ Open. 2021;11(9):e049481. PMID: 34580096. DOI: 10.1136/bmjopen-2021-049481. http://www.ncbi.nlm.nih.gov/pubmed/34580096 +Pubmed +DOI
• Notararigo S, Varela E, Otal A, Cristobo I, Antolín M, Guarner F, Prieto A, López P. Evaluation of an O2-Substituted (1-3)-?-D-Glucan, Produced by Pediococcus parvulus 2.6, in ex vivo Models of Crohn´s Disease. Front Microbiol. 2021;12:621280. PMID: 33613490. DOI: 10.3389/fmicb.2021.621280. http://www.ncbi.nlm.nih.gov/pubmed/33613490 +Pubmed +DOI
• Núñez-Fernández M, Ramos-Hernández C, García-Río F, Torres-Durán M, Nodar-Germiñas A, Tilve-Gómez A, Rodríguez-Fernández P, Valverde-Pérez D, Ruano-Raviña A, Fernández-Villar A. Alterations in Respiratory Function Test Three Months after Hospitalisation for COVID-19 Pneumonia: Value of Determining Nitric Oxide Diffusion. J Clin Med. 2021 May;10(10):2119. PMID: 34068867. DOI: 10.3390/jcm10102119. http://www.ncbi.nlm.nih.gov/pubmed/34068867 +Pubmed +DOI
• Perez Elias MJ, Alejos B, Gutierrez MM, Crespo M, De Los Santos Gil I, Ribera E, Galindo MJ, Lozano F, Payeras Cifre A, Boix V, Montero-Alonso M, Sanz J, De La Torre Lima J, Palacios R, De La Fuente Moral S, Martinez E, Codar Study Group. Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion. J Antimicrob Chemother. 2021 Mar;76(4):1046–50. PMID: 33501995. DOI: 10.1093/jac/dkaa547. http://www.ncbi.nlm.nih.gov/pubmed/33501995 +Pubmed +DOI
• Pérez-de-Llano L, Romay-Lema EM, Baloira-Villar A, Anchorena C, Torres-Durán ML, Sousa A, Corbacho-Abelaira D, Paz-Ferrin J, Diego-Roza C, Vilariño-Maneiro L, Marcos PJ, Montero-Martínez C, de la Iglesia-Martínez F, Riveiro-Blanco V, Rodríguez-Núñez N, Abal-Arca J, Bustillo-Casado M, Golpe R. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation. PLoS One. 2021;16(6):e0253465. PMID: 34161387. DOI: 10.1371/journal.pone.0253465. http://www.ncbi.nlm.nih.gov/pubmed/34161387 +Pubmed +DOI
• Pérez-Rodríguez MT, Sousa A, Moreno-Flores A, Longueira R, Diéguez P, Suárez M, Lima O, Vasallo FJ, Álvarez-Fernández M, Crespo M. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia. Int J Infect Dis. 2021 Jan;102:554–60. PMID: 33157291. DOI: 10.1016/j.ijid.2020.10.097. http://www.ncbi.nlm.nih.gov/pubmed/33157291 +Pubmed +DOI
• Ramos Hernández C, Botana Rial M, Pazos Area LA, Núñez Fernández M, Pérez Fernández S, Rubianes González M, Crespo Casal M, Fernández Villar A. Lung Ultrasound to Predict Unfavorable Progress in Patients Hospitalized for COVID-19. Arch Bronconeumol. 2021 Jan;57 Suppl 1:47–54. PMID: 33067026. DOI: 10.1016/j.arbres.2020.07.043. http://www.ncbi.nlm.nih.gov/pubmed/33067026 +Pubmed +DOI
• Ramos Hernández C, Botana Rial M, Pazos Area LA, Núñez Fernández M, Pérez Fernández S, Rubianes González M, Crespo Casal M, Fernández Villar A. [Lung Ultrasound to Predict Unfavorable Progress in Patients Hospitalized for COVID-19]. Arch Bronconeumol. 2021 Jan;57:47–54. PMID: 34629648. DOI: 10.1016/j.arbres.2020.07.043. http://www.ncbi.nlm.nih.gov/pubmed/34629648 +Pubmed +DOI
• Rodríguez OL, Sousa A, Pérez-Rodríguez MT, Martínez-Lamas L, Suárez RL, Martínez CT, Pino CP, Vidal FV, Pérez-Landeiro A, Casal MC. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia. Medicine (Baltimore). 2021 Apr;100(14):e24880. PMID: 33832068. DOI: 10.1097/MD.0000000000024880. http://www.ncbi.nlm.nih.gov/pubmed/33832068 +Pubmed +DOI
• Rodríguez-Baño J, Pachón J, Carratalà J, Ryan P, Jarrín I, Yllescas M, Arribas JR, Berenguer J, SAM-COVID Study Group(Ma Teresa Pérez-Rodríguez; Adrián Sousa; Alexandre Pérez-González; Rebeca Longueira; Alejandro Araujo), Fundación SEIMC-GESIDA, Hospital Universitario La Paz, Hospital Universitario Gregorio Marañón, Hospital Infanta Leonor, Complejo Hospitalario Virgen de la Salud, Hospital Universitario Rafael Méndez, Hospital Universitario de Cruces, Hospital de Melilla, Hospital San Eloy de Barakaldo, Hospital Universitario Central de Asturias, Hospital Universitario Puerto Real, Hospital do Salnés, Hospital del Mar, Hospital Virgen de la Arrixaca, Hospital Clínico San Cecilio, Parc Sanitari Sant Joan de Déu, Hospital Josep Trueta, Hospital Dos De Maig – Consorci Sanitari Integral, Hospital Clínico Universitario de Valencia, Complejo Asistencial de Ávila, Hospital Universitario Marqués de Valdecilla, Hospital de Barcelona SCIAS, Hospital Álvaro Cunqueiro, Hospital Universitario Severo Ochoa, Hospital CIMA- +Pubmed +DOI
• Solo-Peleteiro A, Diéguez P, Pérez-Rodríguez MT, Galárraga RA, Pérez-Landeiro A, Álvarez-Fernández M. Cerebrospinal fluid drainage-related ventriculitis due to multidrug-resistant microorganisms. Enfermedades Infecc y Microbiol Clin (English ed). 2021 Feb;(E-PUB) PMID: 33593611. DOI: 10.1016/j.eimc.2020.12.010. http://www.ncbi.nlm.nih.gov/pubmed/33593611 +Pubmed +DOI
• Sousa A, Alonso-Herrero A, Pérez-Rodríguez MT, Lima O, Otero A, Suárez M, Longueira R, Martínez-Lamas L, Nodar A, Crespo M. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent. Enfermedades Infecc y Microbiol Clin (English ed). 2021 Sep;39(9):445–50. PMID: 34736748. DOI: 10.1016/j.eimce.2020.07.011. http://www.ncbi.nlm.nih.gov/pubmed/32980185 +Pubmed +DOI
• Suarez-García I, Alejos B, Pérez-Elías M-J, Iribarren J-A, Hernando A, Ramírez M, Tasias M, Pascual M, Jarrin I, Hernando V, CoRIS Cohort [Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada]. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. BMC Womens Health. 2021;21(1):223. PMID: 34049547. DOI: 10.1186/s12905-021-01370-w. http://www.ncbi.nlm.nih.gov/pubmed/34049547 +Pubmed +DOI
• Vallejo Camazon N, Mateu L, Cediel G, Escolà-Vergé L, Fernández-Hidalgo N, Gurgui Ferrer M, Perez Rodriguez MT, Cuervo G, Nuñez Aragón R, Llibre C, Sopena N, Quesada MD, Berastegui E, Teis A, Lopez Ayerbe J, Juncà G, Gual F, Ferrer Sistach E, Vivero A, Reynaga E, Hernández Pérez M, Muñoz Guijosa C, Pedro-Botet L, Bayés-Genís A. Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis. Cardiol J. 2021;28(4):566–78. PMID: 34031866. DOI: 10.5603/CJ.a2021.0054. http://www.ncbi.nlm.nih.gov/pubmed/34031866 +Pubmed +DOI

Scientific Papers

• Alejos B, Suárez-García I, Rava M, Bautista-Hernández A, Gutierrez F, Dalmau D, Sagastagoitia I, Rivero A, Moreno S, Jarrín I, CoRIS (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. J Antimicrob Chemother. 2020 Oct;75(10):3004–14. PMID: 32667674. DOI: 10.1093/jac/dkaa246. http://www.ncbi.nlm.nih.gov/pubmed/32667674 +Pubmed +DOI
• Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, Yllescas M, Arriba JR, COVID-19@Spain Study Group (Ma Teresa Pérez-Rodríguez; Alexandre Pérez-González), Fundación SEIMC-GESIDA, Hospital General Universitario Gregorio Marañón, Hospital Universitario La Paz, Hospital Infanta Leonor, Complejo Hospitalario Virgen de la Salud, Hospital Universitario Rafael Méndez, Hospital Universitario de Cruces, Hospital de Melilla, Hospital San Eloy de Barakaldo, Hospital Universitario Central de Asturias, Hospital General Universitario de Alicante, Hospital Virgen de la Victoria, Hospital Universitario Puerto Real, EOXI Pontevedra e Salnés, Hospital de Figueres, Hospital Sant Jaume de Calella, Hospital del Mar, Hospital Virgen de la Arrixaca, Hospital de Can Misses, Hospital de Sagunto, Hospital Clínico San Cecilio, Hospital Universitario Príncipe de Asturias, Parc Sanitari Sant Joan de Déu, Hospital Nuestra Señora de Gracia, HC Marbella Internacional Hospital, Hospital La Princesa, Hospital Josep Truet +Pubmed +DOI
• Calò F, Retamar P, Martínez Pérez-Crespo PM, Lanz-García J, Sousa A, Goikoetxea J, Reguera-Iglesias JM, León E, Armiñanzas C, Mantecón MA, Rodríguez-Baño J, López-Cortés LE, PROBAC REIPI/GEIH-SEIMC/SAEI. Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort. J Antimicrob Chemother. 2020;75(10):3056–61. PMID: 32688386. DOI: 10.1093/jac/dkaa262. http://www.ncbi.nlm.nih.gov/pubmed/32688386 +Pubmed +DOI
• Casadellà M, Santos JR, Noguera-Julian M, Micán-Rivera R, Domingo P, Antela A, Portilla J, Sanz J, Montero-Alonso M, Navarro J, Masiá M, Valcarce-Pardeiro N, Ocampo A, Pérez-Martínez L, Pasquau J, Vivancos MJ, Imaz A, Carmona-Oyaga P, Muñoz-Medina L, Villar-García J, Barrufet P, Paredes R, INSTINCT Study Group. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping. J Antimicrob Chemother. 2020;75(12):3517–24. PMID: 32929472. DOI: 10.1093/jac/dkaa349. http://www.ncbi.nlm.nih.gov/pubmed/32929472 +Pubmed +DOI
• Corma-Gómez A, Macías J, Lacalle-Remigio JR, Téllez F, Morano L, Rivero A, Serrano M, Ríos MJ, Vera-Méndez FJ, Alados JC, Real LM, Palacios R, Santos IDL, Imatz A, Pineda JA. HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis. Clin Infect Dis. 2020 Aug;(E-PUB) PMID: 32766891. DOI: 10.1093/cid/ciaa1111. http://www.ncbi.nlm.nih.gov/pubmed/32766891 +Pubmed +DOI
• Corma-Gómez A, Macías J, Téllez F, Freyre-Carrillo C, Morano L, Rivero-Juárez A, Ríos MJ, Alados JC, Vera-Méndez FJ, Merchante N, Palacios R, Granados R, Merino D, De Los Santos I, Pineda JA. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals. Clin Infect Dis. 2020 Nov;71(9):2354–62. PMID: 31754695. DOI: 10.1093/cid/ciz1140. http://www.ncbi.nlm.nih.gov/pubmed/31754695 +Pubmed +DOI
• Curran A, Rull A, Navarro J, Vidal-González J, Martin-Castillo M, Burgos J, Falcó V, Ribera E, Torrella A, Planas B, Peraire J, Crespo M. Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. J Clin Med. 2020 Apr;9(5) PMID: 32344934. DOI: 10.3390/jcm9051246. http://www.ncbi.nlm.nih.gov/pubmed/32344934 +Pubmed +DOI
• Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA, The Spanish HIV/COVID-19 Collaboration (A Ocampo; G Pousada). Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy?: A Cohort Study. Ann Intern Med. 2020;173(7):536–41. PMID: 32589451. DOI: 10.7326/M20-3689. http://www.ncbi.nlm.nih.gov/pubmed/32589451 +Pubmed +DOI
• Escolà-Vergé L, Peghin M, Givone F, Pérez-Rodríguez MT, Suárez-Varela M, Meije Y, Abelenda G, Almirante B, Fernández-Hidalgo N. Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):711–7. PMID: 31444092. DOI: 10.1016/j.rec.2019.07.007. http://www.ncbi.nlm.nih.gov/pubmed/31444092 +Pubmed +DOI
• Lago-Docampo M, Tenorio J, Hernández-González I, Pérez-Olivares C, Escribano-Subías P, Pousada G, Baloira A, Arenas M, Lapunzina P, Valverde D. Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients. Sci Rep. 2020;10(1):15135. PMID: 32934261. DOI: 10.1038/s41598-020-72089-1. http://www.ncbi.nlm.nih.gov/pubmed/32934261 +Pubmed +DOI
• Martinez E, Negredo E, Knobel H, Ocampo A, Sanz J, Garcia-Fraile L, Martin-Carbonero L, Lozano F, Gonzalez-Domenech CM, Gutierrez M, Montero M, Boix V, Payeras A, Torralba M, Gonzalez-Cordon A, Moreno A, Alejos B, Perez-Elias MJ, GeSIDA 9316 CODAR Study Group. Factors associated with the number of drugs in darunavir/cobicistat regimens. J Antimicrob Chemother. 2020 Jan;75(1):208–14. PMID: 31586414. DOI: 10.1093/jac/dkz399. http://www.ncbi.nlm.nih.gov/pubmed/31586414 +Pubmed +DOI
• Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L. Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users. Enferm Infecc Microbiol Clin. 2020 Mar;38(3):127–31. PMID: 30415884. DOI: 10.1016/j.eimc.2018.09.006. http://www.ncbi.nlm.nih.gov/pubmed/30415884 +Pubmed +DOI
• Rivero-Juárez A, Aguilera A, Avellón A, García-Deltoro M, García F, Gortazar C, Granados R, Macías J, Merchante N, Oteo JA, Pérez-Gracia MT, Pineda JA, Rivero A, Rodriguez-Lazaro D, Téllez F, Morano-Amado LE, Grupo redactor de GeHEP SEIMC. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enferm Infecc Microbiol Clin. 2020 Jan;38(1):28–32. PMID: 30072282. DOI: 10.1016/j.eimc.2018.06.014. http://www.ncbi.nlm.nih.gov/pubmed/30072282 +Pubmed +DOI
• Serrano-Villar S, Martínez-Sanz J, Ron R, Talavera-Rodríguez A, Fernández-Felix BM, Herrera S, Muriel A, Fanjul F, Portilla J, Muñoz J, Amador C, de Zárraga MA, Vivancos MJ, Moreno S, Spanish HIV Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study. lancet HIV. 2020;7(8):e565–73. PMID: 32763219. DOI: 10.1016/S2352-3018(20)30202-2. http://www.ncbi.nlm.nih.gov/pubmed/32763219 +Pubmed +DOI
• Suárez-García I, Moreno C, Ruiz-Algueró M, Pérez-Elías MJ, Navarro M, Díez Martínez M, Viciana P, Pérez-Martínez L, Górgolas M, Amador C, de Zárraga MA, Jarrín I, Cohort of the Spanish HIV/ADS Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study. AIDS Res Ther. 2020;17(1):45. PMID: 32690099. DOI: 10.1186/s12981-020-00302-2. http://www.ncbi.nlm.nih.gov/pubmed/32690099 +Pubmed +DOI
• Suárez-García I, Ruiz-Algueró M, García Yubero C, Moreno C, Belza MJ, Estébanez M, de Los Santos I, Masiá M, Samperiz Abad G, Muñoz Sánchez J, Omar M, Jarrín I, Cohort of the Spanish HIV/AIDS Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Physicians´ opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain. J Antimicrob Chemother. 2020;75(2):466–72. PMID: 31665404. DOI: 10.1093/jac/dkz439. http://www.ncbi.nlm.nih.gov/pubmed/31665404 +Pubmed +DOI

Book Chapters

• Ocampo-Hermida A, Pérez A. Caso 8. In: Pérez Domínguez L, Facal Álvarez C (eds.). Infección por VIH en Galicia A propósito de nuestros casos clínicos. Grupo Aula Médica, S.L; 2020. p. 37–42. ISBN: 978-8478856701. https://books.google.es/books/about/Infección_por_VIH_en_Galicia.html?id=RQODzgEACAAJ&redir_esc=y Link

Scientific Papers

• AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [Eva Poveda; Antonio Ocampo]. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients. Enferm Infecc Microbiol Clin. 2019 May;37(7):467–75. PMID: 29793873. DOI: 10.1016/j.eimc.2018.03.011. http://www.ncbi.nlm.nih.gov/pubmed/29793873 +Pubmed +DOI
• Cachay ER, Mena A, Morano L, Benitez L, Maida I, Ballard C, Hill L, Torriani F, Castro A, Dore E, Castro S, de Mendoza Fernández C, Soriano V, Mathews WC, HCV-TREN Cohort. Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus. Open forum Infect Dis. 2019 Mar;6(3):ofz070. PMID: 30949524. DOI: 10.1093/ofid/ofz070. http://www.ncbi.nlm.nih.gov/pubmed/30949524 +Pubmed +DOI
• Corma-Gómez A, Macías J, Merino Muñoz D, Téllez F, Granados R, Morano LE, De Los Santos Gil I, Vera-Méndez FJ, Collado A, Palacios R, Pineda JA. Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks. J Infect. 2019;79(1):30–5. PMID: 31100364. DOI: 10.1016/j.jinf.2019.05.005. http://www.ncbi.nlm.nih.gov/pubmed/31100364 +Pubmed +DOI
• Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA, RIS-HEP13 and GEHEP 011 study groups. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS. 2019;33(7):1167–74. PMID: 30845068. DOI: 10.1097/QAD.0000000000002186. http://www.ncbi.nlm.nih.gov/pubmed/30845068 +Pubmed +DOI
• Corredoira J, Miguez E, Mateo LM, Fernández-Rodriguez R, García-Rodriguez JF, Peréz-Gonzalez A, Sanjurjo A, Pulian M V, Rabuñal R, GESBOGA. Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain. Infection. 2019 Jun;47(3):399–407. PMID: 30498902. DOI: 10.1007/s15010-018-1254-x. http://www.ncbi.nlm.nih.gov/pubmed/30498902 +Pubmed +DOI
• Cózar A, Ramos-Martínez A, Merino E, Martínez-García C, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez C, Cuquet J, Gil-Campesino H, Torres L, Sánchez-Porto A, Royuela A, Cobo J, Study group. High delayed mortality after the first episode of Clostridium difficile infection. Anaerobe. 2019 Jun;57:93–8. PMID: 30959165. DOI: 10.1016/j.anaerobe.2019.04.004. http://www.ncbi.nlm.nih.gov/pubmed/30959165 +Pubmed +DOI
• De Mendoza C, Pirón M, Gonzalez R, Jiménez A, Caballero E, Roc L, Benito R, Ramos JM, Soriano V, HTLV Spanish Study Group (S Pérez; L Morano). Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain. Open forum Infect Dis. 2019 Feb;6(2):ofz036. PMID: 30815504. DOI: 10.1093/ofid/ofz036. http://www.ncbi.nlm.nih.gov/pubmed/30815504 +Pubmed +DOI
• Delgado E, Benito S, Montero V, Cuevas MT, Fernández-García A, Sánchez-Martínez M, García-Bodas E, Díez-Fuertes F, Gil H, Cañada J, Carrera C, Martínez-López J, Sintes M, Pérez-Álvarez L, Thomson MM, Spanish Group for the Study of New HIV Diagnoses. Diverse Large HIV-1 Non-subtype B Clusters Are Spreading Among Men Who Have Sex With Men in Spain. Front Microbiol. 2019;10:655. PMID: 31001231. DOI: 10.3389/fmicb.2019.00655. http://www.ncbi.nlm.nih.gov/pubmed/31001231 +Pubmed +DOI
• Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 Aug;12(1):232–46. PMID: 30171206. DOI: 10.1038/s41385-018-0083-7. http://www.ncbi.nlm.nih.gov/pubmed/30171206 +Pubmed +DOI
• Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte J-J, Sow R, Axler O, Maggioni AP, Lancellotti P, EURO-ENDO Investigators (F. Calvo Iglesias; E. Blanco-Gonzalez; M. Bravo Amaro; E. LopezRodriguez; J. Lugo Adan; A.N. Germinas; P. Pazos-Lopez; M. Pereira Loureiro; M.T. Perez; S. Raposeiras-Roubin; S. Rasheed Yas; M-M. Suarez-Varela; F. Vasallo Vidal). Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–32. PMID: 31504413. DOI: 10.1093/eurheartj/ehz620. http://www.ncbi.nlm.nih.gov/pubmed/31504413 +Pubmed +DOI
• Habib G, Lancellotti P, Erba P-A, Sadeghpour A, Meshaal M, Sambola A, Furnaz S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B, Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP, EURO-ENDO Investigators (F. Calvo Iglesias; E. Blanco-Gonzalez; M. Bravo Amaro; E. LopezRodriguez; J. Lugo Adan; A.N. Germinas; P. Pazos-Lopez; M. Pereira Loureiro; M.T. Perez; S. Raposeiras-Roubin; S. Rasheed Yas; M-M. Suarez-Varela; F. Vasallo Vidal). The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Hear journal Qual care Clin outcomes. 2019;5(3):202–7. PMID: 30957862. DOI: 10.1093/ehjqcco/qcz018. http://www.ncbi.nlm.nih.gov/pubmed/30957862 +Pubmed +DOI
• Londoño M-C, Riveiro-Barciela M, Ahumada A, Muñoz-Gómez R, Roget M, Devesa-Medina MJ, Serra MÁ, Navascués CA, Baliellas C, Aldamiz-Echevarría T, Gutiérrez ML, Polo-Lorduy B, Carmona I, Benlloch S, Bonet L, García-Samaniego J, Jiménez-Pérez M, Morán-Sánchez S, Castro Á, Delgado M, Gea-Rodríguez F, Martín-Granizo I, Montes ML, Morano L, Castaño MA, de Los Santos I, Laguno M, Losa JE, Montero-Alonso M, Rivero A, de Álvaro C, Manzanares A, Mallolas J, Barril G, González-Parra E, García-Buey L. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study. PLoS One. 2019;14(9):e0221567. PMID: 31550267. DOI: 10.1371/journal.pone.0221567. http://www.ncbi.nlm.nih.gov/pubmed/31550267 +Pubmed +DOI
• López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold A-M, Lie B, European Scleroderma Group†, Proudman S, Stevens W, Nikpour M, Australian Scleroderma Interest Group (ASIG), Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J, Sousa) ESG (Adrián. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat Commun. 2019;10(1):4955. PMID: 31672989. DOI: 10.1038/s41467-019-12760-y. http://www.ncbi.nlm.nih.gov/pubmed/31672989 +Pubmed +DOI
• Macías J, Granados R, Téllez F, Merino D, Pérez M, Morano LE, Palacios R, Paniagua M, Frías M, Merchante N, Pineda JA, HEPAVIR GEHEP R-H study groups. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. J Viral Hepat. 2019 Jan;26(1):16–24. PMID: 30141222. DOI: 10.1111/jvh.12990. http://www.ncbi.nlm.nih.gov/pubmed/30141222 +Pubmed +DOI
• Macías J, Morano LE, Téllez F, Granados R, Rivero-Juárez A, Palacios R, Ríos M, Merino D, Pérez-Pérez M, Collado A, Figueruela B, Morano A, Freyre-Carrillo C, Martín JM, Rivero A, García F, Pineda JA, HEPAVIR group from the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) and the GEHEP group from the Sociedad Española de Enfermedades Infecciosas y Microbiología (SEIMC). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71(1):45–51. PMID: 30853642. DOI: 10.1016/j.jhep.2019.02.018. http://www.ncbi.nlm.nih.gov/pubmed/30853642 +Pubmed +DOI
• Macías J, Téllez F, Rivero-Juárez A, Palacios R, Morano LE, Merino D, Collado A, García-Fraile L, Omar M, Pineda JA, the HEPAVIR G and R-H study groups. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients. J Viral Hepat. 2019 Sep;26(1):48–54. PMID: 30199593. DOI: 10.1111/jvh.13003. http://www.ncbi.nlm.nih.gov/pubmed/30199593 +Pubmed +DOI
• Manuel Sousa J, Vergara M, Pulido F, Sánchez Antolín G, Hijona L, Carnicer F, Rincón D, Salmerón J, Mateos-Muñoz B, Jou A, Polo-Lorduy B, Rubín Á, Escarda A, Aguilar P, Aldámiz-Echevarría T, García-Buey L, Carrión JA, Hernández-Guerra M, Chimeno-Hernández S, Espinosa N, Morillas RM, Andrade RJ, Delgado M, Gallego A, Magaz M, Moreno-Planas JM, Estébanez Á, Rico M, Menéndez F, Sampedro B, Morano L, Izquierdo S, Zozaya JM, Rodríguez M, Morán-Sánchez S, Lorente S, Martín-Granizo I, Von-Wichmann MÁ, Delgado M, Manzanares A. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain. PLoS One. 2019;14(11):e0225061. PMID: 31714950. DOI: 10.1371/journal.pone.0225061. http://www.ncbi.nlm.nih.gov/pubmed/31714950 +Pubmed +DOI
• Marra E, Lin C, Clifford GM. Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis. J Infect Dis. 2019;219(4):590–8. PMID: 30239749. DOI: 10.1093/infdis/jiy556. http://www.ncbi.nlm.nih.gov/pubmed/30239749 +Pubmed +DOI
• Morón-López S, Navarro J, Jimenez M, Rutsaert S, Urrea V, Puertas MC, Torrella A, De Clercq L, Ribas BP, Gálvez C, Salgado M, Vandekerckhove L, Blanco J, Crespo M, Martinez-Picado J. Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Indi. Clin Infect Dis. 2019;69(8):1320–8. PMID: 30590412. DOI: 10.1093/cid/ciy1095. http://www.ncbi.nlm.nih.gov/pubmed/30590412 +Pubmed +DOI
• Ocampo Hermida A, Longueira Suárez R, Castro Iglesias Á, Asorey Carballeira Á, De la Fuente Aguado J. Despistaje de la infección por el virus de inmunodeficiencia humana en Atención Primaria mediante indicadores de sospecha: estudio DIVAPIS. Galicia Clínica. 2019 Oct;80(4):70. DOI: 10.22546/54/1699. http://doi.org/10.22546/54/1699 +DOI
• Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E, CODAR study group. Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316). J Antimicrob Chemother. 2019;74(10):3044–8. PMID: 31236601. DOI: 10.1093/jac/dkz254. http://www.ncbi.nlm.nih.gov/pubmed/31236601 +Pubmed +DOI
• Pérez-Matute P, Íñiguez M, Villanueva-Millán MJ, Recio-Fernández E, Vázquez AM, Sánchez SC, Morano LE, Oteo JA. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients. Eur J Intern Med. 2019 Sep;67:47–58. PMID: 31221551. DOI: 10.1016/j.ejim.2019.06.005. http://www.ncbi.nlm.nih.gov/pubmed/31221551 +Pubmed +DOI
• Pérez-Rodríguez MT, Sousa A, López-Cortés LE, Martínez-Lamas L, Val N, Baroja A, Nodar A, Vasallo F, Álvarez-Fernández M, Crespo M, Rodríguez-Baño J. Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019;74(4):1101–7. PMID: 30689894. DOI: 10.1093/jac/dky556. http://www.ncbi.nlm.nih.gov/pubmed/30689894 +Pubmed +DOI
• Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanovi? V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d´Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, HIDES Study Group (Antonio Ocampo). Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015. PLoS One. 2019;14(8):e0220108. PMID: 31408476. DOI: 10.1371/journal.pone.0220108. http://www.ncbi.nlm.nih.gov/pubmed/31408476 +Pubmed +DOI
• Requena S, Caballero E, Lozano AB, Ríos-Villegas MJ, Benito R, Rojo S, Cabezas T, Macià MD, Nieto MDC, Soriano V, de Mendoza C, Spanish HIV-2 Study Group. Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain. AIDS. 2019;33(14):2167–72. PMID: 31373918. DOI: 10.1097/QAD.0000000000002338. http://www.ncbi.nlm.nih.gov/pubmed/31373918 +Pubmed +DOI
• Rizzardini G, Gori A, Miralles C, Olalla J, Molina J-M, Raffi F, Kumar P, Antinori A, Ramgopal M, Stellbrink H-J, Das M, Chu H, Ram R, Garner W, Shao Y, Chuck SK, Piontkowsky D, Haubrich RH. Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. AIDS. 2019;33(10):1583–93. PMID: 31305329. DOI: 10.1097/QAD.0000000000002244. http://www.ncbi.nlm.nih.gov/pubmed/31305329 +Pubmed +DOI
• Rosás-Umbert M, Llano A, Bellido R, Olvera A, Ruiz-Riol M, Rocafort M, Fernández MA, Cobarsi P, Crespo M, Dorrell L, Del Romero J, Alcami J, Paredes R, Brander C, Mothe B. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers. J Virol. 2019;93(4) PMID: 30487276. DOI: 10.1128/JVI.01436-18. http://www.ncbi.nlm.nih.gov/pubmed/30487276 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Suarez M, Val N, Martínez-Lamas L, Nodar A, Crespo M. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a ?-lactamase producing organism. Infect Dis (London, England). 2019 Jan;51(1):32–7. PMID: 30371118. DOI: 10.1080/23744235.2018.1508883. http://www.ncbi.nlm.nih.gov/pubmed/30371118 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Suárez M, Val N, Martínez-Lamas L, Nodar A, Longueira R, Crespo M. Short- versus long-course therapy in gram-negative bacilli bloodstream infections. Eur J Clin Microbiol Infect Dis. 2019 May;38(5):851–7. PMID: 30680566. DOI: 10.1007/s10096-019-03467-5. http://www.ncbi.nlm.nih.gov/pubmed/30680566 +Pubmed +DOI
• Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Canorea I, Guardiola JM, Crespo M, Quereda C, Sanz J, Carrero A, Hontañón V, Avellón A, Resino S. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014). Sci Rep. 2019;9(1):1143. PMID: 30718554. DOI: 10.1038/s41598-018-37328-6. http://www.ncbi.nlm.nih.gov/pubmed/30718554 +Pubmed +DOI

Scientific Papers

• AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan [Manuel Crespo; Eva Poveda]. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017). Enferm Infecc Microbiol Clin. 2018 Aug;36(7):435–45. PMID: 28579016. DOI: 10.1016/j.eimc.2017.04.001. http://www.ncbi.nlm.nih.gov/pubmed/28579016 +Pubmed +DOI
• Berenguer J, Jarrín I, Pérez-Latorre L, Hontañón V, Vivancos MJ, Navarro J, Téllez MJ, Guardiola JM, Iribarren JA, Rivero-Juárez A, Márquez M, Artero A, Morano L, Santos I, Moreno J, Fariñas MC, Galindo MJ, Hernando MA, Montero M, Cifuentes C, Domingo P, Sanz J, Domíngez L, Ferrero OL, De la Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, Losa JE, Vilaró J, Bernal E, Arponen S, Ortí AJ, Chocarro Á, Teira R, Alonso G, Silvariño R, Vegas A, Geijo P, Bisbe J, Esteban H, González-García J, GeSIDA 8514 Study Group. Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant. Open forum Infect Dis. 2018 Jan;5(1):ofx258. PMID: 29354658. DOI: 10.1093/ofid/ofx258. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767960/pdf/ofx258.pdf +Pubmed +DOI
• Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodríguez de la Concepción ML, Curriu M, Massanella M, Navarro J, Crespo M, Viñets E, Millá F, Clotet B, Blanco J. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan;32(2):149–60. PMID: 29112067. DOI: 10.1097/QAD.0000000000001686. http://www.ncbi.nlm.nih.gov/pubmed/29112067 +Pubmed +DOI
• Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM, Nosocomial Infection Study Group. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents. 2018 Mar;51(3):393–8. PMID: 28939450. DOI: 10.1016/j.ijantimicag.2017.09.010. http://www.ncbi.nlm.nih.gov/pubmed/28939450 +Pubmed +DOI
• Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang G, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. Gastroenterology. 2018 Oct;155(4):1120-1127.e4. PMID: 29958855. DOI: 10.1053/j.gastro.2018.06.042. http://www.ncbi.nlm.nih.gov/pubmed/29958855 +Pubmed +DOI
• Martinez Lamas L, Pérez-Rodríguez MT, Alvarez Ramos I, Bouza Soage ME, Figueroa Lamas MP, Alvarez Fernandez M, Martínez Lamas L, Pérez Rodríguez MT, Álvarez Ramos I, Bouza Soage ME, Figueroa Lamas MP, Álvarez Fernández M. Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR. Rev Esp Quimioter. 2018 Aug;31(4):336–43. PMID: 29956896. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172691/pdf/revespquimioter-31-336.pdf +Pubmed
• Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S, GESIDA 3603b Study Group. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS. 2018 Jun;32(9):1095–105. PMID: 29438197. DOI: 10.1097/QAD.0000000000001787. http://www.ncbi.nlm.nih.gov/pubmed/29438197 +Pubmed +DOI
• Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D. Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. J Antimicrob Chemother. 2018 Aug;73(8):2171–6. PMID: 29788066. DOI: 10.1093/jac/dky175. http://www.ncbi.nlm.nih.gov/pubmed/29788066 +Pubmed +DOI
• Papst L, Beovi? B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M, ESGAP, ESGBIS E and the C treatment survey study group (Pérez RM. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect. 2018 Oct;24(10):1070–6. PMID: 29410094. DOI: 10.1016/j.cmi.2018.01.015. http://www.ncbi.nlm.nih.gov/pubmed/29410094 +Pubmed +DOI
• Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA, GESIDA 7011 Study Group members (Miralles C; Ocampo A). Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial. J Antimicrob Chemother. 2018 Sep;73(9):2444–51. PMID: 29897573. DOI: 10.1093/jac/dky212. http://www.ncbi.nlm.nih.gov/pubmed/29897573 +Pubmed +DOI
• Piera Rojo G, Fachal Bermudez C, Morano Amado L. Hypochromic skin lesions in Brazilian patient. Med Clin (Barc). 2018 Sep;151(6):e35. PMID: 29276011. DOI: 10.1016/j.medcli.2017.10.040. http://www.ncbi.nlm.nih.gov/pubmed/29276011 +Pubmed +DOI
• Pousada G, Lago-Docampo M, Prado S, Varela-Calviño R, Mantiñán B, Valverde D. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves´ disease patients. J Cell Mol Med. 2018 Mar;22(3):1538–47. PMID: 29266775. DOI: 10.1111/jcmm.13425. http://www.ncbi.nlm.nih.gov/pubmed/29266775 +Pubmed +DOI
• Poveda E, Crespo M. Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of Virological Failure? AIDS Rev. 2018;20(1):71–2. PMID: 29628513. http://www.ncbi.nlm.nih.gov/pubmed/29628513 +Pubmed
• Real LM, Macías J, Pérez AB, Merino D, Granados R, Morano L, Delgado M, Ríos MJ, Galera C, Deltoro MG, Merchante N, García F, Pineda JA. Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Sci Rep. 2018 Oct;8(1):14905. PMID: 30297726. DOI: 10.1038/s41598-018-33367-1. http://www.ncbi.nlm.nih.gov/pubmed/30297726 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Nodar A, Martínez-Lamas L, Vasallo FJ, Álvarez-Fernández M, Crespo M. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease. Enferm Infecc Microbiol Clin. 2018 May;36(5):284–9. PMID: 28648390. DOI: 10.1016/j.eimc.2017.05.003. http://www.ncbi.nlm.nih.gov/pubmed/28648390 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Soto A, Rodríguez L, Pérez-Landeiro A, Martínez-Lamas L, Nodar A, Crespo M. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2018 Nov;73(11):3170–5. PMID: 30099490. DOI: 10.1093/jac/dky295. http://www.ncbi.nlm.nih.gov/pubmed/30099490 +Pubmed +DOI

Clinical Practice Guidelines

• Panel de expertos de GeSIDA (Manuel Crespo – Coord; Antonio Ocampo). Documento de consenso de GeSIDA sobre control y monitorización de la infección por VIH (2018). Crespo-Casal M, Lozano F (eds.). GESIDA; 2018. http://gesida-seimc.org/wp-content/uploads/2018/01/gesida_DC_Control_y_Monitorizacion_b23_01_18.pdf Link

Scientific Papers

• Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J, GESIDA HIV/HCV Cohort Study Group. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology. 2017 Aug;66(2):344–56. PMID: 28109003. DOI: 10.1002/hep.29071. IF2017: 14.079; D1. http://www.ncbi.nlm.nih.gov/pubmed/28109003 +Pubmed +DOI
• Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group. Enferm Infecc Microbiol Clin. 2017 Oct;35(8):493–8. PMID: 27061975. DOI: 10.1016/j.eimc.2016.02.029. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27061975 +Pubmed +DOI
• de Mendoza C, Caballero E, Aguilera A, Requena S, de Lejarazu RO, Pirón M, González R, Jiménez A, Roc L, Treviño A, Benito R, Fernández-Alonso M, Aguinaga A, Rodríguez C, García-Costa J, Blanco L, Ramos JM, Calderón E, Eirós JM, Sauleda S, Barreiro P, Soriano V, Spanish HTLV Network (Morano L; Pérez-Castro S; Poveda E). Human T-lymphotropic virus type 1 infection and disease in Spain. AIDS. 2017 Jul;31(12):1653–63. PMID: 28700391. DOI: 10.1097/QAD.0000000000001527. IF2017: 4.914; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28700391 +Pubmed +DOI
• Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, Ocaña I, Ribera E, Torrella A, Planas B, Badía R, Castellví J, Falcó V, Crespo M, Buzon MJ. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. Prasad VR (ed.). MBio. 2017 Sep;8(4):e00876-17. PMID: 28698276. DOI: 10.1128/mBio.00876-17. IF2017: 6.689; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28698276 +Pubmed +DOI
• Iribarren Díaz M, Ocampo Hermida A, González-Carreró Fojón J, Longueira Suárez R, Rivera Gallego A, Casal Núñez E, Ocampo Álvarez A, Cachay ER. Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain. Rev Esp Enferm Dig. 2017 Apr;109(4):242–9. PMID: 28229612. DOI: 10.17235/reed.2017.4274/2016. IF2017: 1.632; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28229612 +Pubmed +DOI
• Lopez Diez E, Perez S, Inarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodriguez M, Montero R, Ojea A, López Diez E, Pérez S, Iñarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodríguez M, Montero R, Ojea A. Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions. Enferm Infecc Microbiol Clin. 2017 May;35(5):273–7. PMID: 27004428. DOI: 10.1016/j.eimc.2016.02.014. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27004428 +Pubmed +DOI
• Mateos-Lindemann ML, Pérez-Castro S, Rodríguez-Iglesias M, Pérez-Gracia MT. Microbiological diagnosis of human papilloma virus infection. Enferm Infecc Microbiol Clin. 2017 Nov;35(9):593–602. PMID: 27353835. DOI: 10.1016/j.eimc.2016.05.008. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27353835 +Pubmed +DOI
• Moreno S, Antela A, García F, Del Amo J, Boix V, Coll P, Fortuny C, Sirvent JLG, Gutiérrez F, Iribarren JA, Llibre JM, Quirós JCLB de, Losa JE, Lozano A, Meulbroek M, Olalla J, Pujol F, Pulido F, Crespo Casal M, García JG, Aldeguer JL, Molina JAP, Podzamczer Palter D, Román AR, Grupo Redactor de GESIDA/SEIMC. Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016. Enferm Infecc Microbiol Clin. 2017 Jun;35(6):377–83. PMID: 28236498. DOI: 10.1016/j.eimc.2016.11.016. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28236498 +Pubmed +DOI
• Navarro J, Laguno M, Vilchez HH, Guardiola JM, Carrion JA, Force L, Cairó M, Cifuentes C, Vilaró J, Cucurull J, Marco A, Roget M, Erice E, Crespo M, Catalano-Balear Study Group. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients. J Antimicrob Chemother. 2017 Oct;72(10):2850–6. PMID: 29091196. DOI: 10.1093/jac/dkx223. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/29091196 +Pubmed +DOI
• Pernas B, Rego-Pérez I, Tabernilla A, Balboa V, Relaño S, Grandal M, Crespo M, Mena Á, Castro-Iglesias Á, Blanco FJ, Poveda E. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication. J Antimicrob Chemother. 2017 Nov;72(11):3159–62. PMID: 28961892. DOI: 10.1093/jac/dkx272. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/28961892 +Pubmed +DOI
• Poveda E, Crespo M. When is Early Antiretroviral Therapy Early Enough for HIV Remission? AIDS Rev. 2017 Apr;19(2):113–4. PMID: 28534887. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28534887 +Pubmed
• Poveda E, Puoti M, García-Deltoro M, Pineda JA, Téllez F, Granados R, Morano L, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP). News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference. AIDS Rev. 2017 Jan;19(1):47–53. PMID: 28182613. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28182613 +Pubmed
• Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88–99. PMID: 27459919. DOI: 10.1016/j.eimc.2016.06.013. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27459919 +Pubmed +DOI
• Rodríguez-Da Silva A, Miralles C, Ocampo A, Valverde D. [Prevalence study of the genetic markers associated with slow progression of human inmunodefiency virus type 1 in the Galician population (Northwest of Spain)]. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):104–7. PMID: 26100217. DOI: 10.1016/j.eimc.2015.04.006. IF2017: 1.707; Q3; JCR-CAT: MICROBIOLOGY. http://www.ncbi.nlm.nih.gov/pubmed/26100217 +Pubmed +DOI
• Rodríguez-Osorio I, Cid P, Morano L, Castro Á, Suárez M, Delgado M, Margusino L, Meijide H, Pernas B, Tabernilla A, Pedreira JD, Mena Á, Poveda E. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. J Clin Virol. 2017 Mar;88:58–61. PMID: 28183063. DOI: 10.1016/j.jcv.2017.01.003. IF2017: 3.101; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28183063 +Pubmed +DOI
• Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA. Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM. Grce M (ed.). PLoS One. 2017 Nov;12(11):e0188851. PMID: 29190817. DOI: 10.1371/journal.pone.0188851. IF2017: 2.766; Q1. http://www.ncbi.nlm.nih.gov/pubmed/29190817 +Pubmed +DOI
• Sousa Dominguez A, Pérez-Rodríguez MT, Nodar A, Martinez-Lamas L, Perez-Landeiro A, Crespo Casal M. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam. J Antimicrob Chemother. 2017 Dec;72(4):1262–3. PMID: 27999042. DOI: 10.1093/jac/dkw526. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/27999042 +Pubmed +DOI

Clinical Practice Guidelines

• Panel de expertos AEEH/SEIMC (Manuel Crespo). Guías AEEH/SEIMC de manejo de la Hepatitis C. Pineda JA, Rivero A, Forns X, Calleja JL (eds.). AEEH/SEIMC; 2017. http://aeeh.es/wp-content/uploads/2017/03/documento-consenso.pdf Link

Scientific Papers

• Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145–50. PMID: 26304492. DOI: 10.1016/j.arbres.2015.07.007. IF2016: 2.979; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26304492 +Pubmed +DOI
• Ferenci P, Caruntu FA, Lengyel G, Messinger D, Bakalos G, Flisiak R, TriCo, Study Group (L MORANO). Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Infect Dis Ther. 2016 Jun;5(2):113–24. PMID: 27228998. DOI: 10.1007/s40121-016-0110-5. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27228998 +Pubmed +DOI
• Fernández-García A, Delgado E, Cuevas MT, Vega Y, Montero V, Sánchez M, Carrera C, López-Álvarez MJ, Miralles C, Pérez-Castro S, Cilla G, Hinojosa C, Pérez-Álvarez L, Thomson MM. Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain. PLoS One. 2016;11(2):e0148549. PMID: 26900693. DOI: 10.1371/journal.pone.0148549. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26900693 +Pubmed +DOI
• Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, Blanco JR, Iribarren M, De Sanjosé S, Hernández-Novoa B, Ortiz M, Del Amo J, CoRIS-HPV Study Group. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors. AIDS. 2016 Jan;30(1):37–44. PMID: 26355673. DOI: 10.1097/QAD.0000000000000874. IF2016: 5.003; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26355673 +Pubmed +DOI
• Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517–23. PMID: 27056581. DOI: 10.1016/j.eimc.2016.02.025. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27056581 +Pubmed +DOI
• Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):516.e1-516.e18. PMID: 26976381. DOI: 10.1016/j.eimc.2016.02.004. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26976381 +Pubmed +DOI
• Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao J-H, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson A-M, Voss F, Gallivan J-P, Böcher WO, Ferenci P. Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials. Ann Hepatol. 2016 Apr;15(3):333–49. PMID: 27049487. DOI: 10.5604/16652681.1198803. IF2016: 1.678; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27049487 +Pubmed +DOI
• Marcellin P, Ahn SH, Chuang W-L, Hui AJ, Tabak F, Mehta R, Petersen J, Lee C-M, Ma X, Caruntu FA, Tak WY, Elkhashab M, Lin L, Wu G, Martins EB, Charuworn P, Yee LJ, Lim SG, Foster GR, Fung S, Morano L, Samuel D, Agarwal K, Idilman R, Strasser SI, Buti M, Gaeta GB, Papatheodoridis G, Flisiak R, Chan HLY. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Aliment Pharmacol Ther. 2016 Nov;44(9):957–66. PMID: 27629859. DOI: 10.1111/apt.13779. IF2016: 7.286; D1. http://www.ncbi.nlm.nih.gov/pubmed/27629859 +Pubmed +DOI
• Márquez A, Fernández-Aranguren T, Witte T, González-Gay MA, Martín J, Spanish GCA Group, Spanish Scleroderma Group (Mayka Freire; Adrián Sousa). LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. Clin Exp Rheumatol. 2016;34 Suppl 1(5):208–9. PMID: 27462831. IF2016: 2.634; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27462831 +Pubmed
• Pérez Parente D, Suárez Santamaría M, Suárez Ordóñez S, Morano Amado LE. Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C. Rev Port Pneumol. 2016 Jan;22(1):57–9. PMID: 26422338. DOI: 10.1016/j.rppnen.2015.08.004. IF2016: 1.560; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26422338 +Pubmed +DOI
• Poveda E, Crespo M. New Strategies for a Comprehensive Fight Against HIV Infection using Monoclonal Antibody Therapy. AIDS Rev. 2016 Jul;18(3):166. PMID: 27721508. IF2016: 3.195; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27721508 +Pubmed
• Riera M, Esteban H, Suarez I, Palacios R, Lozano F, Blanco JR, Valencia E, Ocampo A, Amador C, Frontera G, vonWichmann-de Miguel MA, GESIDA Study Group of the HIV quality indicators. [Validation and adhesion to GESIDA quality indicators in patients with HIV infection]. Enferm Infecc Microbiol Clin. 2016 Jun;34(6):346–52. PMID: 26530224. DOI: 10.1016/j.eimc.2015.09.003. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26530224 +Pubmed +DOI
• Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C, Domingo P, Montero M, del Rio L, Fontdevila J, Perez I, Cruceta A, Gatell JM, Arnedo M, Martínez E. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. HIV Med. 2016 May;17(5):340–9. PMID: 27089862. DOI: 10.1111/hiv.12314. IF2016: 3.257; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27089862 +Pubmed +DOI
• Serrano-Villar S, Gutiérrez F, Miralles C, Berenguer J, Rivero A, Martínez E, Moreno S. Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions. Open forum Infect Dis. 2016 Apr;3(2):ofw097. PMID: 27419169. DOI: 10.1093/ofid/ofw097. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27419169 +Pubmed +DOI
• Vega Y, Delgado E, de la Barrera J, Carrera C, Zaballos Á, Cuesta I, Mariño A, Ocampo A, Miralles C, Pérez-Castro S, Álvarez H, López-Miragaya I, García-Bodas E, Díez-Fuertes F, Thomson MM. Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes. Buratti E (ed.). PLoS One. 2016 Jun;11(6):e0158525. PMID: 27355361. DOI: 10.1371/journal.pone.0158525. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27355361 +Pubmed +DOI
• Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study. AIDS Care. 2016 Oct;28(10):1321–6. PMID: 27140483. DOI: 10.1080/09540121.2016.1173640. IF2016: 1.824; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27140483 +Pubmed +DOI

Book Chapters

• Crespo-Casal M. Infecciones causadas por el virus del herpes simple y de la Varicela-Zóster. In: Rozman Borstnar C, Cardellach Lo?pez F (eds.). Farreras-Rozman Medicina Interna (XVIII Edición). 18th ed. Barcelona: Elsevier Health Sciences Spain; 2016. p. 2313–6. ISBN: 978-84-9022-996-5. http://media.axon.es/pdf/109425.pdf Link

Clinical Practice Guidelines

• Grupo Redactor de GESIDA/PNS (Manuel Crespo). Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización 2016). Rivero A, Polo R, Pérez-Molina JA (eds.). GESIDA, PNS; 2016.

Scientific Papers

• Álvarez-Argüelles ME, de Oña-Navarro M, Rojo-Alba S, Torrens-Muns M, Junquera-Llaneza ML, Antonio-Boga J, Pérez-Castro S, Melón-García S. Quantification of human papilloma virus (HPV) DNA using the Cobas 4800 system in women with and without pathological alterations attributable to the virus. J Virol Methods. 2015 Sep;222:95–102. PMID: 26057221. DOI: 10.1016/j.jviromet.2015.05.016. IF2015: 1.508; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26057221 +Pubmed +DOI
• Delgado E, Cuevas MT, Domínguez F, Vega Y, Cabello M, Fernández-García A, Pérez-Losada M, Castro MÁ, Montero V, Sánchez M, Mariño A, Álvarez H, Ordóñez P, Ocampo A, Miralles C, Pérez-Castro S, López-Álvarez MJ, Rodríguez R, Trigo M, Diz-Arén J, Hinojosa C, Bachiller P, Hernáez-Crespo S, Cisterna R, Garduño E, Pérez-Álvarez L, Thomson MM. Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe. PLoS One. 2015 Nov;10(11):e0143325. PMID: 26599410. DOI: 10.1371/journal.pone.0143325. IF2015: 3.057; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26599410 +Pubmed +DOI
• Pérez-Molina JA, Pulido F, Comité de expertos del Grupo para el Estudio del Sida (GESIDA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) [Celia Miralles]. [How is the implementation of the new legal framework for health care affecting HIV-infected immigrants in an irregular situation in Spain?]. Enferm Infecc Microbiol Clin. 2015 Aug;33(7):437–45. PMID: 25553717. DOI: 10.1016/j.eimc.2014.10.017. http://www.ncbi.nlm.nih.gov/pubmed/25553717 +Pubmed +DOI
• Pérez-Rodríguez MT, Sousa A, Martínez-Cueto P, Ocampo-Hermida A. HIV encephalitis related to the development of a discordant resistant virus in CNS. Clin Microbiol Infect. 2015 Aug;21(8):e59-60. PMID: 25980354. DOI: 10.1016/j.cmi.2015.05.003. IF2015: 4.575; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25980354 +Pubmed +DOI
• Poveda E, Wyles D, Morano L, Pineda JA, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP), E P, D W, L M, JA P, F G, GEHEP. News on HIV-HCV coinfection: Update from the 2015 GEHEP conference. AIDS Rev. 2015 Oct;17(4):231–7. PMID: 26616846. IF2015: 2.068; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26616846 +Pubmed

Scientific Papers

• Feijoo J, Eirea M, Limeres J, Abeleira M, Ramos I, Ocampo A, Diz P. HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin. Oral Dis. 2014 Apr;20(3):313–8. PMID: 23607445. DOI: 10.1111/odi.12116. IF: 2.427; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23607445 +Pubmed +DOI
• Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19520. PMID: 25394029. DOI: 10.7448/ias.17.4.19520. IF: 5.090; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25394029 +Pubmed +DOI
• Martínez E, Jódar Gimeno E, Reyes García R, Carpintero P, Casado JL, Del Pino Montes J, Domingo Pedrol P, Estrada V, Maalouf J, Negredo E, Ocampo A, Muñoz-Torres M, Grupo de Estudio de Sida, Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Investigación Ósea y del Metabolismo Mineral, Sociedad Española de Fractura Osteoporótica. [Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients]. Enferm Infecc Microbiol Clin. 2014 Apr;32(4):250–8. PMID: 24332711. DOI: 10.1016/j.eimc.2013.07.008. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24332711 +Pubmed +DOI
• Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact. Enfermedades Infecc y Microbiol cli?nica. 2014 Oct;32(8):479–85. PMID: 24274937. DOI: 10.1016/j.eimc.2013.09.011. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24274937 +Pubmed +DOI
• Podzamczer D, Imaz A, Perez I, Viciana P, Valencia E, Curto J, Martín T, Castaño M, Rojas J, Espinosa N, Moreno V, Asensi V, Iribarren JA, Clotet B, Force L, Bachiller P, Knobel H, López Bernaldo De Quirós JC, Blanco JR, Rozas N, Vergas J, Ocampo A, Camacho A, Flores J, Gomez-Sirvent JL, KIDAR Study Group. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients. J Antimicrob Chemother. 2014 Sep;69(9):2536–40. PMID: 24833755. DOI: 10.1093/jac/dku157. IF: 5.313; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24833755 +Pubmed +DOI
• Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, Vergara A, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Muñoz J, Fernandez P, Geijo P, de Castro ER, Diz J, Casado A, Torres C. ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19814. PMID: 25397558. IF: 5.090; Q1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4225323&tool=pmcentrez&rendertype=abstract +Pubmed
• Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. [Initial antiretroviral treatment in human immunodeficiency virus-infected patients in Spain: Decisions made in relation to particular immunovirological characteristics (PERFIL-es study)]. Enferm Infecc Microbiol Clin. 2014 Mar;32(2):93–5. PMID: 24144784. DOI: 10.1016/j.eimc.2013.08.002. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24144784 +Pubmed +DOI